PubRank

B L Powell

Author PubWeight™ 55.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 1994 5.03
2 Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 2.33
3 Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med 1995 2.33
4 Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998 2.33
5 Rapid intravenous infusion of amphotericin B: a pilot study. Am J Med 1992 2.18
6 Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association. N Engl J Med 1991 1.89
7 Diagnosis and subclassification of primary and recurrent lymphoma. The usefulness and limitations of combined fine-needle aspiration cytomorphology and flow cytometry. Am J Clin Pathol 2000 1.73
8 Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. J Clin Oncol 1994 1.48
9 Granuloma annulare and disseminated herpes zoster. Int J Dermatol 1992 1.39
10 Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood 2001 1.38
11 A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 1998 1.35
12 Secondary malignancies of the penis and epididymis: a case report and review of the literature. J Clin Oncol 1985 1.31
13 Relationship of progesterone- and estradiol-binding proteins in Coccidioides immitis to coccidioidal dissemination in pregnancy. Infect Immun 1983 1.25
14 Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420. J Clin Oncol 1999 1.19
15 Mucormycosis of the mandible after dental extractions in a patient with acute myelogenous leukemia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 1.07
16 Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. Leukemia 2011 1.05
17 The management of nausea and vomiting in clinical oncology. Am J Med Sci 1987 1.05
18 Receiving mixed signals: uncoupling oligodendrocyte differentiation and myelination. Cell Mol Life Sci 2007 1.04
19 High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood 2001 1.03
20 Improved technique for isolation of Mycobacterium kansasii from water. J Clin Microbiol 1981 0.98
21 Bone marrow cytogenetic abnormalities of aplastic anemia. Am J Hematol 2001 0.97
22 Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364. Blood 1999 0.95
23 Confirmation of corticosterone and progesterone binding activity in Candida albicans. J Infect Dis 1983 0.95
24 A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia. Leukemia 2013 0.95
25 Improvement of long-term survival in extensive small-cell lung cancer. J Clin Oncol 1988 0.90
26 The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia. Leukemia 2012 0.89
27 Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association. J Clin Oncol 1988 0.85
28 Focal neurologic signs associated with hyperkalemia. South Med J 1984 0.83
29 Thymoma. Am Fam Physician 1984 0.83
30 Secondary penile malignancies. Dis Colon Rectum 1986 0.83
31 Identification of a high-affinity binder for estradiol and a low-affinity binder for testosterone in Coccidioides immitis. Infect Immun 1984 0.83
32 Monosomy X as a recurring sole cytogenetic abnormality associated with myelodysplastic diseases. Cancer Genet Cytogenet 1997 0.83
33 Ara-C syndrome during low-dose continuous infusion therapy. Med Pediatr Oncol 1986 0.83
34 Venous thrombosis as a cause of superior vena cava syndrome. Rapid response to streptokinase. Arch Intern Med 1983 0.83
35 The safety of dental extractions in patients with hematologic malignancies. J Clin Oncol 1989 0.82
36 Prospective evaluation of changes in computed cranial tomography in patients with small cell lung carcinoma treated with chemotherapy and prophylactic cranial irradiation. J Clin Oncol 1984 0.81
37 Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytarabine. Semin Hematol 1991 0.81
38 Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disorders. Infect Control Hosp Epidemiol 1990 0.80
39 Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease. Bone Marrow Transplant 1999 0.80
40 Altered oxidative product formation in neutrophils of patients recovering from therapy for acute leukemia. Blood 1986 0.79
41 Radiation recall phenomenon associated with arsenic trioxide. Leukemia 2003 0.78
42 Studies on the dissociation of prolactin from mammary tumor membranes. Endocrinology 1978 0.78
43 High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association. J Clin Oncol 1990 0.78
44 Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3)). Leukemia 2007 0.77
45 Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia 2016 0.76
46 Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias. Semin Oncol 1987 0.76
47 The control of the 24 hour rhythm of colour change in juvenile Carcinus maenas (L). Proc R Ir Acad B 1966 0.76
48 Estrogen receptor measurement in low-protein breast cancer cytosols. A modified charcoal technique. Breast Cancer Res Treat 1981 0.76
49 Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemia. Leuk Lymphoma 2002 0.75
50 Current approaches to acute promyelocytic leukemia. Cancer Treat Res 1999 0.75
51 Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma. Cancer Res 1977 0.75
52 Focal leukemia around a Raaf catheter as the initial site of relapse. Am J Med 1986 0.75
53 Sequential hemibody irradiation integrated into a chemotherapy-local radiotherapy program for limited disease small cell lung cancer. Int J Radiat Oncol Biol Phys 1986 0.75
54 Combination cisplatin and carboplatin in advanced squamous cell carcinoma of the head and neck. Cancer Invest 1996 0.75
55 Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia. Semin Oncol 1985 0.75
56 Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies. Semin Oncol 1985 0.75
57 Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study. Cancer Treat Rep 1987 0.75
58 Thorotrast. N C Med J 1984 0.75
59 Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysis. Int J Radiat Oncol Biol Phys 1985 0.75
60 Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemia. Scand J Haematol Suppl 1986 0.75
61 Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia. J Clin Oncol 1986 0.75
62 Vincristine infusion with CHOP-CCNU in diffuse large-cell lymphoma. Cancer Invest 1990 0.75
63 Purification and characterization of the melanin-dispersing hormone from the sinus gland of the shore crab Carcinus maenas (L.). Gen Comp Endocrinol 1971 0.75
64 Cutaneous reactions to azacitidine. Arch Dermatol 1991 0.75
65 Antiemetic therapy in patients treated with high-dose cytosine arabinoside. Oncology 1987 0.75
66 Thyroid cancer. Am Fam Physician 1984 0.75
67 A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study. Cancer 1990 0.75
68 Overwhelming infection after splenectomy: a challenge to preventive medicine. N C Med J 1985 0.75
69 Cure of hepatic candidiasis in acute leukemia. N C Med J 1986 0.75
70 Adjuvant chemotherapy of solid tumors. Am J Med Sci 1987 0.75
71 Mitoxantrone and high-dose ara-C in refractory malignancies: a phase I trial. Med Pediatr Oncol 1989 0.75
72 Infusion of etoposide and vincristine in non-Hodgkin's lymphoma. Sel Cancer Ther 1989 0.75
73 Chimeric fusion proteins--diphtheria toxin-based. Curr Opin Investig Drugs 2001 0.75
74 Multiple myeloma. Arch Intern Med 1984 0.75
75 A follow-up on a case report. N C Med J 1987 0.75
76 Leukemic infiltration of the esophagus. Cancer 1993 0.75
77 Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies. Cancer Chemother Pharmacol 1987 0.75